The Molecular Basis of COX-2 Versus COX-1 Selectivity of Lumiracoxib by Molecular Docking Studies

By  

Letters in Drug Design & Discovery, Vol. 4, Iss. 6, 2007-09 ,pp. : 422-425

Bentham Science Publishers

Access to resources Recommend Favorite

In Silico Approach to Inhibition of Tyrosinase by Ascorbic Acid Using Molecular Docking Simulations

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 12, 2014-06 ,pp. : 1469-1472

Bentham Science Publishers

Access to resources Recommend Favorite

Structural Approach for COX-2 Inhibition

By  

Mini Reviews in Medicinal Chemistry, Vol. 4, Iss. 6, 2004-08 ,pp. : 603-615

Bentham Science Publishers

Access to resources Recommend Favorite

1-R-2-([1,2,4]Triazolo[1,5-c]quinazoline-2-ylthio)etanon(ol)s: Synthesis, Bioluminescence Inhibition, Molecular Docking Studies, Antibacterial and Antifungal Activities

By  

Current Computer - Aided Drug Design, Vol. 12, Iss. 1, 2016-03 ,pp. : 29-41

Bentham Science Publishers

Access to resources Recommend Favorite

Structural and Molecular Docking Studies of 4-Benzyl-3-[(1-methylpyrrol- 2-yl)methyl]-4,5-dihydro-1H-1,2,4-triazol-5-one with Anticancer Activity

By  

Medicinal Chemistry, Vol. 9, Iss. 3, 2013-05 ,pp. : 313-328

Bentham Science Publishers

Access to resources Recommend Favorite